Search
for
Sort by
Research 61–90 of 1000+
- PRIDE Complex (Papulopustules and/or Paronychia, Regulatory Abnormalities of Hair Growth, Itching, Dryness Due to EGFR Inhibitors)
- Scarring hair follicle destruction is driven by the collapse of EGFR-protected JAK-STAT1-sensitive stem cell immune privilege
- Síndrome PRIDE: una práctica forma de identificar los efectos adversos cutáneos de los inhibidores del EGFR
- MARIO LACOUTURE: How Do I Treat a Patient with Dermatologic Toxicities to EGFR Inhibitors?
- Synthesis, Characterisation, andIn VitroAnticancer Activity of Curcumin Analogues Bearing Pyrazole/Pyrimidine Ring Targeting EGFR Tyrosine Kinase
- Role for the Epidermal Growth Factor Receptor in Chemotherapy-Induced Alopecia
- Dermatological side effects of epidermal growth factor receptor inhibitors: ′Pride′ complex
- Scalp Pustule as a Manifestation of Erlotinib-Induced Skin Toxicity: Report of Two Cases and Literature Review
- 546 Epidermal growth factor receptor as a key regulator of the immune privilege
- Hair eruption initiates and commensal skin microbiota aggravate adverse events of anti-EGFR therapy
- ISID1338 - Epidermal growth factor receptor protects from immune privilege collapse and scarring hair follicle destruction
- A novel approach to manage skin toxicity caused by therapeutic agents targeting epidermal growth factor receptor
- Abstract 18: Targeted epidermal ablation of EGFR causes local and systemic inflammation
- Piperonylic Acid Promotes Hair Growth by Activation of EGFR and Wnt/β-Catenin Pathway
- Topical Application of Aprepitant Inhibits Erlotinib-induced Facial Dermatitis/Hair Loss
- Rash from EGFR inhibitors: Opportunities and challenges for palliation
- Folliculitis Decalvans-like Alopecia During Treatment With EGFR Inhibitors for Lung Cancer: A Case Series of 6 Patients
- Glycyrrhizic Acid Alleviates Osimertinib‐Induced Cutaneous Toxicity by Inhibiting Keratinocyte Apoptosis and Inflammation
- Epidermal growth factor receptor inhibitor Geftinib-induced erosive pustular dermatosis of the scalp – A report with a brief review of the literature
- Dacomitinib-Induced Paronychia Associated With PRIDE Syndrome in a Patient With Non-Small Cell Lung Cancer
- The Cutaneous Epidermal Growth Factor Network: Can it be Translated Clinically to Stimulate Hair Growth? - eScholarship
- Drug Repurposing Patent Applications April–June 2021
- Erlotinib-Associated Alopecia in a Lung Cancer Patient
- When bugs and drugs conspire: driving acneiform skin toxicity
- Adverse Hair Reactions to New Targeted Therapies for Cancer
- Cutaneous Adverse Events of Tyrosine Kinase Inhibitors in Endocrine Tumors: Clinical Features, Mechanisms, and Management Strategies
- Cetuximab-induced hypertrichosis of the scalp and eyelashes
- Eyelash Trichomegaly: A Rare Presenting Feature of Systemic Lupus Erythematosus.
- Epidermal Growth Factor Induces Proliferation of Hair Follicle-Derived Mesenchymal Stem Cells Through Epidermal Growth Factor Receptor-Mediated Activation of ERK and AKT Signaling Pathways Associated with Upregulation of Cyclin D1 and Downregulation of p16
- Recombinant Oil-Body-Expressed Oleosin-hFGF5 in Arabidopsis thaliana Regulates Hair Growth